Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

The pumpkin seed oil niosomes are promising for skin and hair treatments because they are stable and effectively deliver the oil.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

The upper half of a human hair follicle can grow a new hair in a mouse, but success is rare.

mTORC1 signaling needed for quick hair follicle recovery after radiation damage.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Adding human fat-derived stem cells to hair follicle grafts greatly increases hair growth.

People with alopecia areata may be more likely to have a certain type of hearing loss.

New cell-based therapies may improve hair loss treatments in the future.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Greying hairs may be protected from alopecia areata.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Outside factors like grooming, chemicals, and the environment can damage hair and cause disorders.

Nanoparticles can speed up wound healing and deliver drugs effectively but may have potential toxicity risks.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Keratin injections can promote hair growth by affecting hair-forming cells and tissue development.